Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.

2.

Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP.

J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21.

PMID:
21097940
3.

Dispelling the chronic Lyme disease myth.

Kemperman MM, Bakken JS, Kravitz GR.

Minn Med. 2008 Jul;91(7):37-41.

PMID:
18714930
4.

Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.

Wormser GP, Barthold SW, Shapiro ED, Dattwyler RJ, Bakken JS, Steere AC, Bockenstedt LK, Radolf JD.

J Infect Dis. 2007 Dec 15;196(12):1865-6; author reply 1866-7. doi: 10.1086/523826. No abstract available.

PMID:
18190269
5.

A critical appraisal of "chronic Lyme disease".

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L.

N Engl J Med. 2007 Oct 4;357(14):1422-30. Review. No abstract available. Erratum in: N Engl J Med. 2008 Mar 6;358(10):1084. Agger, WA [added]; Artsob, H [added]; Auwaerter, P [added]; Dumler, JS [added]; Bakken, JS [added]; Bockenstedt, LK [added]; Green, J [added]; Dattwyler, RJ [added]; Munoz, J [added]; Nadelman, RB [added]; Schwartz, I [added]; Draper, T [added]; McSweegan,.

PMID:
17914043
6.

Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.

Bakken JS, Dumler JS.

Ann N Y Acad Sci. 2006 Oct;1078:236-47. Review.

PMID:
17114714
7.

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB.

Clin Infect Dis. 2006 Nov 1;43(9):1089-134. Epub 2006 Oct 2. Erratum in: Clin Infect Dis. 2007 Oct 1;45(7):941.

PMID:
17029130
8.
9.

Serological evidence of human granulocytic ehrlichiosis in Norway.

Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE.

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):829-32.

PMID:
8950565
10.

Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Pancholi P, Kolbert CP, Mitchell PD, Reed KD Jr, Dumler JS, Bakken JS, Telford SR 3rd, Persing DH.

J Infect Dis. 1995 Oct;172(4):1007-12.

PMID:
7561173
11.

Ehrlichial diseases of humans: emerging tick-borne infections.

Dumler JS, Bakken JS.

Clin Infect Dis. 1995 May;20(5):1102-10. Review.

PMID:
7619983

Supplemental Content

Loading ...
Support Center